PATENT CLAIM ANALYSIS

Application Number: 16120946
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["435", "007100"]

Abstract:
Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. Described are means and methods for determining antibodies against homocitrulline-containing proteins or carbamylated proteins/peptides (anti-CarP) for the classification of individuals suffering from, or at risk of suffering from, arthritis.

Claim (Index 7):
The method according to  claim 5 , wherein the arthritis comprises rheumatoid arthritis, juvenile arthritis, psoriatic arthritis, osteoarthritis, polymyalgia rheumatica, ankylosing spondylitis, reactive arthritis, gout, pseudogout, autoimmune arthritis, systemic lupus erythematosus, polymyositis, fibromyalgia, Lyme disease, undifferentiated arthritis, non-rheumatoid arthritis or spondyloarthropathy.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.34146
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15478461', '13983374', '15791354', '14806515', '13510091']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7046316445734074
- 35 USC 102 Novelty (BERT): 0.7121304919489954
- Combined Prediction Score: 0.7053815293109663
- Mean Citation Score: 620.167762
- Max Citation Score: 879.2645
- Similarity Product: 733.4933684497474

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test